Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

35
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
35
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
1.1K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

3.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updates on Minimally Invasive Treatment of Adrenal Tumors.

Cancers·2026
Same author

Advances in Adrenal Surgery: An Update.

Journal of laparoendoscopic & advanced surgical techniques. Part A·2026
Same author

Management Approach of Adrenal Incidentaloma.

Journal of laparoendoscopic & advanced surgical techniques. Part A·2026
Same author

Mineralocorticoid Receptor Antagonist Discontinuation in Adrenal Venous Sampling for Subtyping Patients With Primary Hyperaldosteronism: A Systematic Review and Meta-Analysis.

Clinical endocrinology·2026
Same author

Steroid replacement after adrenalectomy for mild autonomous cortisol secretion: Clinical predictors and a practical algorithm.

Surgery·2025
Same author

Local Tumor Control of Liver Tumors After Histotripsy: A Preliminary National Multicenter Study.

JCO oncology practice·2025
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Apr 29, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

26.6K

Adrenocortical cancer update.

Ryaz Chagpar1, Allan E Siperstein1, Eren Berber1

  • 1Section of Endocrine Surgery, Endocrinology and Metabolism Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

The Surgical Clinics of North America
|May 27, 2014
PubMed
Summary
This summary is machine-generated.

Diagnosing adrenocortical cancer (ACC) preoperatively remains challenging, impacting surgical success and leading to high recurrence rates. Advances in diagnostics, surgical techniques, and therapies offer new hope for improved patient outcomes.

Keywords:
Adrenal imagingAdrenalectomyAdrenocortical cancerEndocrinopathyMitotane

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 29, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

26.6K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K

Area of Science:

  • Oncology
  • Endocrinology
  • Surgical Oncology

Background:

  • Preoperative diagnosis of adrenocortical cancer (ACC) relies on clinical, biochemical, and radiologic features, but diagnostic uncertainty persists.
  • This ambiguity can lead to inadequate surgical resection, contributing to poor disease-free survival and high locoregional recurrence rates, even after apparent complete resection (R0).

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of adrenocortical cancer.
  • To highlight the impact of improved diagnostic criteria, surgical techniques, and novel multimodality therapies on patient outcomes.

Main Methods:

  • Review of current literature on adrenocortical cancer diagnosis and treatment.
  • Analysis of the impact of refined diagnostic criteria and surgical approaches.
  • Evaluation of emerging multimodality therapies.

Main Results:

  • Despite improvements, diagnostic challenges in adrenocortical cancer remain.
  • Inadequate resection due to diagnostic ambiguity is a significant factor in poor survival.
  • High rates of locoregional recurrence persist post-surgery.

Conclusions:

  • Refined diagnostic criteria and surgical techniques are crucial for improving adrenocortical cancer treatment.
  • Novel multimodality therapies show promise for enhancing patient outcomes.
  • Continued research and advancements offer renewed hope for managing adrenocortical cancer effectively.